ALFA Finder
10:51 IST
BSE
Other Announcement
Natco Pharma Other Announcement
Natco Pharma filed its shareholding pattern with a reporting date of 23 October 2026. Promoter and promoter group hold about 46% of total equity.
Natco Pharma Ltd
Natco Pharma Ltd news stories on ALFA NewsRead the news →- Share price
- ₹808.95
- Market cap
- ₹15,869 Cr
- Revenue (annual)
- ₹4,078 Cr
- Net profit (annual)
- ₹1,418 Cr
- P/E (TTM)
- 13.9×Sector 43.8×
- Promoter holding
- 46.22%-3.20% QoQ
- FII holding
- 15.37%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Capital Structure Change 5Other Announcement 3Fund Raise 3Earnings Call 3Board Meeting Date 3Annual General Meeting 3Acquisition 3Share Pledge 2Promoter Selling (Off-Market) 1Product Launch 1Financial Results 1Employee Stock Options 1Dividend 1Business Update 1Annual Report 1
Time
3 announcements with these filters
16:55 IST
BSE
Other Announcement
Natco Pharma Other Announcement
Natco Pharma Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026. This filing is a routine regulatory compliance submission.
20:32 IST
BSE
Other Announcement
Natco Pharma Other Announcement
Natco Pharma Limited has filed its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26.